{"doi":"10.4161/onci.22409","title":"An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells","abstract":null,"journal":"OncoImmunology","year":2013,"id":645983,"datarank":0.49983067652628066,"base_score":3.332204510175204,"endowment":3.332204510175204,"self_citation_contribution":0.49983067652628066,"citation_network_contribution":0.0,"self_endowment_contribution":0.49983067652628066,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":27,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":646534,"name":"Ilio Vitale","orcid":"0000-0002-5918-1841","position":1,"is_corresponding":false},{"id":1682252,"name":"Isabelle Martins","orcid":null,"position":2,"is_corresponding":false},{"id":257793,"name":"Oliver Kepp","orcid":"0000-0002-6081-9558","position":3,"is_corresponding":false},{"id":308266,"name":"Lorenzo Galluzzi","orcid":"0000-0003-2257-8500","position":4,"is_corresponding":false},{"id":90484,"name":"Laurence Zitvogel","orcid":"0000-0003-1596-0998","position":5,"is_corresponding":false},{"id":1682258,"name":"Maria Castedo","orcid":null,"position":6,"is_corresponding":false},{"id":49720,"name":"Guido Kroemer","orcid":"0000-0002-9334-4405","position":7,"is_corresponding":false},{"id":1682248,"name":"Laura Senovilla","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells","abstract":"One of the driving forces of oncogenesis is tetraploidy, a duplication of the DNA content that, upon asymmetric cell division or progressive chromosome loss, can originate aneuploidy. Recent findings from our group indicate the existence of an immunosurveillance system that eliminates tetraploid cancer cells. We surmise that tetraploidy-inducing chemotherapeutic agents may elicit potent anticancer responses by re-activating this immunosurveillance system.","is_dataset_classified":null,"base_score":3.332204510175204,"endowment":3.332204510175204,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23482968","pmcid":"PMC3583917","openalex_id":"https://openalex.org/W1987796132","authors":[],"funders":[],"total_grants":0,"fwci":1.9366,"citation_percentile":0.84288991,"influential_citations":0,"citation_trend":[{"year":2013,"count":6},{"year":2014,"count":6},{"year":2015,"count":3},{"year":2016,"count":2},{"year":2017,"count":1},{"year":2019,"count":2},{"year":2020,"count":4},{"year":2021,"count":1},{"year":2022,"count":1},{"year":2023,"count":1}],"oa_status":"gold","license":"cc-by-nc","oa_locations":[{"url":"https://www.tandfonline.com/doi/pdf/10.4161/onci.22409?needAccess=true","host_type":"journal"},{"url":"https://www.tandfonline.com/doi/pdf/10.4161/onci.22409?needAccess=true","host_type":"publisher"},{"url":"http://www.tandfonline.com/doi/pdf/10.4161/onci.22409","host_type":"publisher"},{"url":"https://doi.org/10.4161/onci.22409","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/23482968","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3583917","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC3583917","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC3583917?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Microtubule and mitosis dynamics","RNA Interference and Gene Delivery","Chromosomal and Genetic Variations"],"mesh_terms":[],"keywords":["Immunosurveillance","Carcinogenesis","Aneuploidy","Cancer research","Cancer","Biology","Medicine","Chromosome","Immunology","Genetics","Tumor cells","Gene","calreticulin","breast carcinoma","Hmgb1","Mitotic Catastrophe","Immunogenic Cell Death","Hyperploidy"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-09T10:58:29.071386Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}